academic journal | Q737498 |
open-access journal | Q773668 |
scientific journal | Q5633421 |
P6981 | ACNP journal ID | 3174340 |
P8375 | Crossref journal ID | 208486 |
P6180 | Dimensions Source ID | 1035819 |
P5115 | Directory of Open Access Journals ID | 2195-7819 |
P236 | ISSN | 2195-7819 |
P7363 | ISSN-L | 2195-7819 |
P1277 | JUFO ID | 75407 |
P4730 | Mir@bel journal ID | 9980 |
P1055 | NLM Unique ID | 101603561 |
P856 | official website | http://link.springer.com/journal/40504 |
http://www.lsspjournal.com/ | ||
P10283 | OpenAlex ID | S2739080197 |
P3181 | OpenCitations bibliographic resource ID | 622 |
P12834 | PMC journal ID | 2747 |
P7662 | Scilit journal ID | 1990080 |
P1156 | Scopus source ID | 21100466413 |
P5983 | Springer journal ID | 40504 |
P166 | award received | DOAJ seal | Q73548471 |
P972 | catalog | Directory of Open Access Journals | Q1227538 |
P275 | copyright license | Creative Commons Attribution | Q6905323 |
P6216 | copyright status | copyrighted | Q50423863 |
P17 | country | United Kingdom | Q145 |
P495 | country of origin | Germany | Q183 |
P8875 | indexed in bibliographic review | Scopus | Q371467 |
Emerging Sources Citation Index | Q22908122 | ||
P407 | language of work or name | English | Q1860 |
P123 | publisher | Springer Science+Business Media | Q176916 |
BioMed Central | Q463494 | ||
P1476 | title | Life sciences, society and policy |
Q30847779 | "A good collaboration is based on unique contributions from each side": assessing the dynamics of collaboration in stem cell science |
Q41667833 | 'Mr Cummings clearly does not understand the science of genetics and should maybe go back to school on the subject': an exploratory content analysis of the online comments beneath a controversial news story |
Q28607239 | 'Pop-Up' Governance: developing internal governance frameworks for consortia: the example of UK10K |
Q37672342 | A paedophile scan to prevent child sexual abuse in child care? A thought experiment to problematize the notion of alignment in Responsible Research and Innovation |
Q89738728 | A socio-psychological model of laser levelling impacts assessment |
Q47410233 | A statistician's perspective on digital epidemiology |
Q38879425 | A strategic stakeholder approach for addressing further analysis requests in whole genome sequencing research |
Q21146609 | Adapt or perish? Assessing the recent shift in the European research funding arena from 'ELSA' to 'RRI' |
Q92621917 | Addressing research integrity challenges: from penalising individual perpetrators to fostering research ecosystem quality care |
Q96609710 | Allonymous science: the politics of placing and shifting credit in public-private nutrition research |
Q41877661 | An ethical assessment model for digital disease detection technologies |
Q36339052 | Bio-objectifying European bodies: standardisation of biobanks in the Biobanking and Biomolecular Resources Research Infrastructure |
Q114061056 | Biobanking and risk assessment: a comprehensive typology of risks for an adaptive risk governance |
Q45755073 | Bringing in the controversy: re-politicizing the de-politicized strategy of ethics committees. |
Q92426905 | Broad consent under the GDPR: an optimistic perspective on a bright future |
Q59127343 | CRISPR as agent: a metaphor that rhetorically inhibits the prospects for responsible research |
Q38994624 | Challenges for the European governance of synthetic biology for human health |
Q28647937 | Challenges of web-based personal genomic data sharing |
Q57173056 | Clinical exome sequencing in France and Quebec: what are the challenges? What does the future hold? |
Q99637588 | Consolidating RRI and Open Science: understanding the potential for transformative change |
Q57159116 | Constructing future scenarios as a tool to foster responsible research and innovation among future synthetic biologists |
Q35868291 | Constructing populations in biobanking. |
Q42725853 | Continental philosophical perspectives on life sciences and emerging technologies |
Q36137737 | Cord blood banking - bio-objects on the borderlands between community and immunity |
Q35883555 | Could the organ shortage ever be met? |
Q58765810 | Creating life and the media: translations and echoes |
Q41636562 | Creative tensions: mutual responsiveness adapted to private sector research and development |
Q48101547 | Crisis Communication in Public Health Emergencies: The Limits of 'Legal Control' and the Risks for Harmful Outcomes in a Digital Age. |
Q28602023 | DIY-Bio - economic, epistemological and ethical implications and ambivalences |
Q63246317 | Digital epidemiology and global health security; an interdisciplinary conversation |
Q47207173 | Digital epidemiology: what is it, and where is it going? |
Q35780095 | Direct to consumer testing in reproductive contexts--should health professionals be concerned? |
Q51782573 | Disease detection, epidemiology and outbreak response: the digital future of public health practice. |
Q56395640 | Disease surveillance data sharing for public health: the next ethical frontiers |
Q35780101 | ELSA and RRI--Editorial |
Q36289619 | Early detection of criminality concerns and the social link |
Q50350782 | Editors introduction: biobanks as sites of bio-objectification |
Q42577098 | Erratum to: Islet Xeno/transplantation and the risk of contagion: local responses from Canada and Australia to an emerging global technoscience |
Q36396291 | Ethical acceptability of research on human-animal chimeric embryos: summary of opinions by the Japanese Expert Panel on Bioethics |
Q28607430 | Ethical considerations of research policy for personal genome analysis: the approach of the Genome Science Project in Japan |
Q38616422 | Ethical sharing of health data in online platforms - which values should be considered? |
Q37474885 | Evaluating determinants of rural Villagers' engagement in conservation and waste management behaviors based on integrated conceptual framework of Pro-environmental behavior. |
Q57935386 | Evolutionary tinkering vs. rational engineering in the times of synthetic biology |
Q33665232 | Farmer-suicide in India: debating the role of biotechnology. |
Q45755100 | Forensic DNA databases in European countries: is size linked to performance? |
Q45755218 | Frankenstein 2.0.: Identifying and characterising synthetic biology engineers in science fiction films. |
Q45755161 | From ELSA to responsible research and Promisomics. |
Q52581615 | Genomics? That is probably GM! The impact a name can have on the interpretation of a technology. |
Q100520325 | Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's disease |
Q102062542 | Governance of research consortia: challenges of implementing Responsible Research and Innovation within Europe |
Q26798331 | Governing the research-care divide in clinical biobanking: Dutch perspectives |
Q97887798 | Health is a political choice: why conduct healthcare research? Value, importance and outcomes to policy makers |
Q30974300 | Health research access to personal confidential data in England and Wales: assessing any gap in public attitude between preferable and acceptable models of consent |
Q38626507 | How biological background assumptions influence scientific risk evaluation of stacked genetically modified plants: an analysis of research hypotheses and argumentations |
Q48110645 | How medical technologies shape the experience of illness |
Q98227014 | How should researchers cope with the ethical demands of discovering research misconduct? Going beyond reporting and whistleblowing |
Q57122771 | How to do things with metaphors: engineering life as hodgepodge |
Q50016766 | I'm shocked: informed consent in ECT and the phenomenological-self |
Q112627153 | Identifying violence against the LGTBI+ community in Catalan universities |
Q55407780 | Individuals on alert: digital epidemiology and the individualization of surveillance. |
Q35883568 | Institutionalising ELSA in the moment of breakdown? |
Q30382357 | Integrated assessment of emerging science and technologies as creating learning processes among assessment communities. |
Q54959919 | Is there a duty to participate in digital epidemiology? |
Q26779812 | Islet Xeno/transplantation and the risk of contagion: local responses from Canada and Australia to an emerging global technoscience |
Q98665640 | Just data? Solidarity and justice in data-driven medicine |
Q28607428 | Limiting and facilitating access to innovations in medicine and agriculture: a brief exposition of the ethical arguments |
Q55065668 | Machine metaphors and ethics in synthetic biology. |
Q61818194 | Mapping do-it-yourself science |
Q37201404 | Mars ain't the kind of place to raise your kid: ethical implications of pregnancy on missions to colonize other planets |
Q45755190 | Motivation in the age of genomics: why genetic findings of disease susceptibility might not motivate behavior change. |
Q30386834 | Nature is (a) mine: conceptions of nature in the Dutch ecogenomics community. |
Q34495683 | Neglected ethical issues in biobank management: Results from a U.S. study |
Q45755234 | New life sciences innovation and distributive justice: rawlsian goods versus senian capabilities. |
Q30375794 | Obituary for Herbert Gottweis, Professor of Political Science, University of Vienna: Born 8 February 1958 in Vienna, died 31 March 2014 in Vienna. |
Q28269896 | Open Genetic Code: on open source in the life sciences |
Q30974296 | Open consent, biobanking and data protection law: can open consent be 'informed' under the forthcoming data protection regulation? |
Q27316610 | Parental perspectives on consent for participation in large-scale, non-biological data repositories |
Q45754958 | Patient and family trajectories of mitochondrial disease: diversity, uncertainty and genetic risk. |
Q45755036 | Perceptions of nature, nurture and behaviour. |
Q35780090 | Precaution, governance and the failure of medical implants: the ASR((TM)) hip in the UK |
Q41947776 | Product, not process! Explaining a basic concept in agricultural biotechnologies and food safety |
Q64285848 | Questioning the rhetoric of a 'willing population' in Finnish biobanking |
Q28083176 | Reflections on different governance styles in regulating science: a contribution to 'Responsible Research and Innovation'. |
Q45755173 | Relatively (im) material: mtDNA and genetic relatedness in law and policy. |
Q59401608 | Resuscitation and resurrection: The ethics of cloning cheetahs, mammoths, and Neanderthals |
Q45755267 | S. Jasanoff (ed.): Reframing Rights: Bioconstitutionalism in the Genetic Age: Cambridge MA: MIT Press, 2011. |
Q55116441 | Scientific iconoclasm and active imagination: synthetic cells as techno-scientific mandalas. |
Q59789843 | Scientific mistakes from the agri-food biotech critics |
Q53858844 | Services in the self: embodied labor and the global bioeconomy. |
Q37586002 | Sharpening the cutting edge: additional considerations for the UK debates on embryonic interventions for mitochondrial diseases |
Q94539005 | Sociological factors influencing the performance of organic activities in Iran |
Q91389593 | Souled out of rights? - predicaments in protecting the human spirit in the age of neuromarketing |
Q55499948 | Synthetic biology in the German press: how implications of metaphors shape representations of morality and responsibility. |
Q41537055 | Synthetic biology, metaphors and responsibility |
Q101136989 | THE FUTURE OF MEDICINE, healthcare innovation through precision medicine: policy case study of Qatar |
Q47131533 | Teilhard de Chardin's oeuvre within an ongoing discussion of a gene drive release for public health reasons |
Q55365563 | The biogenetical revolution of the Council of Europe - twenty years of the Convention on Human Rights and Biomedicine (Oviedo Convention). |
Q45755009 | The bioinformatics of genetic origins: how identities become embedded in the tools and practices of bioinformatics. |
Q42290427 | The body as constitutive element phenomenology and psychoanalysis on our view of ourselves and others |
Q35883482 | The evolution of withdrawal: negotiating research relationships in biobanking |
Q111035080 | The funhouse mirror: the I in personalised healthcare |
Q58050593 | The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project |
Q36391433 | The intersection of relational autonomy and narrative ethics for the patient unwilling to disclose genetic diagnosis information |
Q45755140 | The lore of low methane livestock: co-producing technology and animals for reduced climate change impact. |
Q36678411 | The moral concerns of biobank donors: the effect of non-welfare interests on willingness to donate |
Q30399453 | The oblique perspective: philosophical diagnostics of contemporary life sciences research |
Q35883661 | The past and future of RRI |
Q100402119 | The reconfiguration of biobanks in Europe under the BBMRI-ERIC framework: towards global sharing nodes? |
Q30375791 | The role of philosophy of science in Responsible Research and Innovation (RRI): the case of nanomedicine. |
Q41680694 | The social dimension of biobanking: objectives and challenges |
Q28607339 | The use of agrobiodiversity for plant improvement and the intellectual property paradigm: institutional fit and legal tools for mass selection, conventional and molecular plant breeding |
Q114969881 | The use of digital twins in healthcare: socio-ethical benefits and socio-ethical risks |
Q36923224 | Towards a phronetic space for responsible research (and innovation) |
Q33736238 | Towards new human rights in the age of neuroscience and neurotechnology |
Q41203100 | Transformation of intimacy and its impact in developing countries |
Q30383217 | Turning the tide or surfing the wave? Responsible Research and Innovation, fundamental rights and neoliberal virtues. |
Q64068752 | Understanding social oocyte freezing in Italy: a scoping survey on university female students' awareness and attitudes |
Q57058979 | Understanding the emotion of shame in transgender individuals - some insight from Kafka |
Q35859308 | Unexpected tissue and the biobank that closed: an exploration of value and the momentariness of bio-objectification processes |
Q49721805 | Unscripted Responsible Research and Innovation: Adaptive space creation by an emerging RRI practice concerning juvenile justice interventions |
Q36289568 | We have never been ELSI researchers - there is no need for a post-ELSI shift |
Q99585941 | What is the impact of patient recruitment on offshoring of clinical trials? |
Q63976731 | Who are the users of synthetic DNA? Using metaphors to activate microorganisms at the center of synthetic biology |
Q33785328 | Young people's awareness on biobanking and DNA profiling: results of a questionnaire administered to Italian university students |
Q111856354 | “Data is the new oil”: citizen science and informed consent in an era of researchers handling of an economically valuable resource |
Search more.